RameshVNathanMDFIDSA

PubMed

• Appropriate cleaning reduces potential risk of spore transmission from patients with Clostridioides difficile infection treated in outpatient infusion centers.
  Claudia P Schroeder, Richard L Hengel, Ramesh V Nathan, Timothy E Ritter, Engels N Obi, Chris Lancaster, Lucinda J Van Anglen, Kevin W Garey> ;Anaerobe. 2022 Oct 1
• 7 citations
  Recurrent Clostridioides difficile infection worsens anxiety-related patient-reported quality of life.
  Richard L Hengel, Claudia P Schroeder, Jinhee Jo, Timothy E Ritter, Ramesh V Nathan, Anne J Gonzales-Luna, Engels N Obi, Ryan J Dillon, Lucinda J Van Anglen, Kevin W G...> ;Journal of Patient-Reported Outcomes. 2022 May 14
• 22 citations
  A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2.
  Ramesh Nathan, Imad Shawa, Inmaculada de la Torre, Jennifer M. Pustizzi, Natalie Haustrup, Dipak R. Patel, Gregory D Huhn> ;Infectious Diseases and Therapy. 2021 Aug 10
• Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
  Dougan M, Nirula A, Azizad M, Mocherla B, Gottlieb RL, Chen P, Hebert C, Perry R, Boscia J, Heller B, Morris J, Crystal C, Igbinadolor A, Huhn G, Cardona J, Shawa I, K...> ;The New England journal of medicine. 2021-07-14
• 2 citations
  Using a nurse-initiated bedside tool to decrease inappropriate testing for Clostridioides difficile in hospital settings:
  Amy Lenz, Genevieve Davis, Hoda Asmar, Arby Nahapetian, John Dingilian, Ramesh V Nathan> ;Journal of Infection Prevention. 2021 May 1
• SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.
  Chen P, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V, Shawa I, Adams AC, Van Naarden J, Custer KL, Shen L, Durante M, O...> ;The New England journal of medicine. 2020-10-28
• 29 citations
  Real-world Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study.
  Richard L Hengel, Timothy E. Ritter, Ramesh V Nathan, Lucinda J. Van Anglen, Claudia P. Schroeder, Ryan J Dillon, Stephen Marcella, Kevin W. Garey> ;Open Forum Infectious Diseases. 2020 Mar 19
• 114 citations
  The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation.
  Arthur Jeng, Manie Beheshti, John Li, Ramesh Nathan> ;Medicine. 2010 Jul 1
• 10 citations
  Suspected immune reconstitution inflammatory syndrome associated with the proliferation of Kaposi's sarcoma during HAART.
  Ramesh V Nathan> ;AIDS. 2007 Mar 30
• 29 citations
  In-Hospital Observation After Antibiotic Switch in Pneumonia: A National Evaluation
  Ramesh V. Nathan, David C. Rhew, Cynthia K. Murray, Dale W. Bratzler, Peter M. Houck, Scott Weingarten> ;The American Journal of Medicine. 2006 Jun 1
• Join now to see all

Journal Articles

• The Role of Beta-Hemolytic Streptococci in Causing Diffuse, Non-Culturable Cellulitis: A Prospective Investigation  
  Jeng A, Beheshti M, Li J, Nathan R, Medicine, 1/1/2010
• Listerosis  
  Nathan RV, 5 minute Clinical Consult, 1/1/2008
• Suspected Immune Reconstitution Inflammatory Syndrome associated with the Proliferation of Kaposi’s Sarcoma during HAART  
  Nathan R, AIDS, 1/30/2007
• In Hospital Observation after Switch from Intravenous to Oral Antibiotics for Patients with Community-Acquired Pneumonia: A National Evaluation  
  Nathan RV, Rhew D., American Journal of Medicine, 1/1/2006
• Join now to see all

Abstracts/Posters

• Ceftolozane/Tazobactam For Treatment of Gram negative infections
  Nathan R et al, IDweek, New Orleans, 10/29/2016
• Antimicrobial Regimen and Safety of Pediatric Outpatient Treatment in a Physician Office Infusion Center (POIC)
  Nathan RV, Metzger B, Bernett J, Prokesch R, Luu Q, Couch K, Schroeder C, IDWeek, San Diego, CA, 1/1/2015
• A Nationwide Outpatient Experience in Physician Office Infusion Centers (POIC’s)
  Van Anglen L, Dretler R, Luu Q, Nathan RV, Statner B, Alvarado F, Schroeder C Dalbavancin, IDWeek, San Diego, CA, 1/1/2015
• Thirty Day Readmission Rates in Patients Receiving Outpatient Parenteral Antimicrobial Therapy
  Mandel R, Nathan RV, IDWeek, Philadelphia, PA, 1/1/2014
• Vancomycin Experience in Physician Office Infusion Centers
  Nathan RV et al, IDWeek, San Francisco, CA, 1/1/2013
• Outpatient Parenteral Antimicrobial Therapy for Complicated Intra-abdominal Infections in Physician Office Infusion Centers
  Alvarado F, Nathan RV et al, IDWeek, San Francisco, CA, 1/1/2013
• Incidence, Treatment, Outcomes and Recurrent Rates for Clostridium Difficile Infection (CDI) in Patients Receiving Intravenous Antibiotic Therapy through Physician Off...
  Nathan RV et al, IDWeek, San Diego, CA, 1/1/2012
• Clostridium difficile incidence and outcomes for patients treated in physician office infusion centers
  Nathan R et al, IDSA Annual meeting, 10/2011
• Join now to see all

Lectures

• Successful Treatment of Gram Negative Sinopulmonary Infections in Infectious Disease Physician Office Infusion Centers 
  Vancouver, Canada - 1/1/2010
• Effect of a Decolonization Protocol to Prevent Recurrent MRSA Infections in Outpatients 
  Philadelphia, PA - 10/1/2009
• The Role of Beta-Hemolytic Streptococci versus Staphylococcus Aureus in causing Non-Culturable Skin and Soft Tissue Infections 
  IDSA AnnualSan Francisco, CA - 1/1/2005